On June 26, 2020, Wired UKfeatured insights from AFAR expert Nir Barzilai, MD, on how targeting the biology of aging can help target COVID-19, particularly with drugs that are already available on the market such as metformin and rapamycin.
Metformin will be tested in the upcoming AFAR-funded Targeting Aging with Metformin (TAME) Trial.
Dr. Barzilai is AFAR’s Scientific Director, a 1994 Glenn Foundation for Medical Research and AFAR Grants for Junior Faculty recipient, a 1997 Paul B. Beeson Emerging Leaders Career Development Award in Aging scholar, a 2010 Irving S. Wright Award winner, and the Director at the Institute for Aging Research and distinguished Professor at the Albert Einstein College of Medicine.
Joan Mannick, MD, Co-Founder and Chief Medical Officer of resTORbio, was also a guest presenter in our recent webinar, “COVID-19: Can the Science of Aging Move Us Forward?”
Read the article, “To slow the coronavirus death toll we may need to slow down ageing,” here.
Watch the recent webinar here, or watch presenter clips here.
